Kuhn RJ - Search Results

1

Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.

Flume PA, Mogayzel PJ Jr, Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, Marshall BC; Clinical Practice Guidelines for Pulmonary Therapies Committee. Flume PA, et al. Among authors: kuhn rj. Am J Respir Crit Care Med. 2009 Nov 1;180(9):802-8. doi: 10.1164/rccm.200812-1845PP. Epub 2009 Sep 3. Am J Respir Crit Care Med. 2009. PMID: 19729669 Review.

2

Treatment options for cystic fibrosis: case study and panel discussion.

Kuhn RJ, Flume PA. Kuhn RJ, et al. Pharmacotherapy. 2002 Mar;22(3 Pt 2):86S-87S. doi: 10.1592/phco.22.6.86s.33908. Pharmacotherapy. 2002. PMID: 11898886 No abstract available.

3

Economic impact of tobramycin in patients with cystic fibrosis in a managed care population.

Wertz DA, Chang CL, Stephenson JJ, Zhang J, Kuhn RJ. Wertz DA, et al. Among authors: kuhn rj. J Med Econ. 2011;14(6):759-68. doi: 10.3111/13696998.2011.621004. Epub 2011 Sep 27. J Med Econ. 2011. PMID: 21942462 Free article.

4

WSV2023 - The second meeting of the world society for virology: One health - One world - One virology.

Abdel-Moneim AS, Murovska M, Söderlund-Venermo M, Vakharia VN, Wilson WC, Gladue DP, Moore MD, Alonso C, Abdelwahab SF, Venter M, Malik YS, Zhengli S, Saxena SK, Varma A, Kuhn RJ. Abdel-Moneim AS, et al. Among authors: kuhn rj. Virology. 2024 Jun;594:110049. doi: 10.1016/j.virol.2024.110049. Epub 2024 Mar 15. Virology. 2024. PMID: 38527382

5

A decade of change: The evolution of pharmacy services at U.S. cystic fibrosis centers.

Grube PM, Autry EB, Kormelink LN, Young DC, Zobell JT, Bhakta ZN, Schadler AD, Kuhn RJ. Grube PM, et al. Among authors: kuhn rj. Pediatr Pulmonol. 2024 Mar;59(3):652-661. doi: 10.1002/ppul.26798. Epub 2023 Dec 5. Pediatr Pulmonol. 2024. PMID: 38050809

6

Assessment of long-term medication adherence with cystic fibrosis: An integrated approach.

Platt T, Kormelink LN, Autry EB, Rossoll SJ, Kuhn RJ. Platt T, et al. Among authors: kuhn rj. Pediatr Pulmonol. 2024 Feb;59(2):458-464. doi: 10.1002/ppul.26774. Epub 2023 Nov 29. Pediatr Pulmonol. 2024. PMID: 38018665

7

Antiviral evaluation of 1,4-disubstituted-1,2,3-triazole derivatives against Chikungunya virus.

Rabelo VW, da Silva VD, Sanchez Nuñez ML, Dos Santos Corrêa Amorim L, Buarque CD, Kuhn RJ, Abreu PA, Nunes de Palmer Paixão IC. Rabelo VW, et al. Among authors: kuhn rj. Future Virol. 2023 Sep;18(13):865-880. doi: 10.2217/fvl-2023-0142. Epub 2023 Oct 25. Future Virol. 2023. PMID: 37974899

8

A Prototype-Pathogen Approach for the Development of Flavivirus Countermeasures.

Kuhn RJ, Barrett ADT, Desilva AM, Harris E, Kramer LD, Montgomery RR, Pierson TC, Sette A, Diamond MS. Kuhn RJ, et al. J Infect Dis. 2023 Oct 18;228(Suppl 6):S398-S413. doi: 10.1093/infdis/jiad193. J Infect Dis. 2023. PMID: 37849402 Review.

9

Structure of Vibrio Phage XM1, a Simple Contractile DNA Injection Machine.

Wang Z, Fokine A, Guo X, Jiang W, Rossmann MG, Kuhn RJ, Luo ZH, Klose T. Wang Z, et al. Among authors: kuhn rj. Viruses. 2023 Jul 31;15(8):1673. doi: 10.3390/v15081673. Viruses. 2023. PMID: 37632015 Free PMC article.

10

Efficacy of an isoxazole-3-carboxamide analog of pleconaril in mouse models of Enterovirus-D68 and Coxsackie B5.

Lane TR, Fu J, Sherry B, Tarbet B, Hurst BL, Riabova O, Kazakova E, Egorova A, Clarke P, Leser JS, Frost J, Rudy M, Tyler KL, Klose T, Volobueva AS, Belyaevskaya SV, Zarubaev VV, Kuhn RJ, Makarov V, Ekins S. Lane TR, et al. Among authors: kuhn rj. Antiviral Res. 2023 Aug;216:105654. doi: 10.1016/j.antiviral.2023.105654. Epub 2023 Jun 14. Antiviral Res. 2023. PMID: 37327878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

300 results

Search Page